Rakuten Medical signs manufacturing agreement with LOTTE Biologics

ElpasBio partners with Fosun Kairos on AlloJoin stem cell therapy

argenx secures FDA priority review for VYVGART in seronegative myasthenia gravis

TetraScience collaborates with Thermo Fisher Scientific to accelerate scientific data and AI enablement

Curasight reports preliminary data from Phase 1 trial in patients with high-grade gliomas

Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA

WuXi Biologics granted UK GMP certification for two manufacturing facilities in Wuxi

Viking Therapeutics publishes Phase 2 data showing up to 14.7% weight loss with VK2735

NewcelX reports positive biomaterial study results supporting stem cell islet delivery without immune suppression

Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer

Sanofi's Teizeild approved in EU to delay stage 3 type 1 diabetes

Futura Medical reports statistically significant female sexual function gains in WSD4000 study

GRIN Therapeutics doses first patient in global Phase 3 trial of investigational radiprodil for GRIN-NDD

Phanes Therapeutics reports clinical data on spevatamig chemotherapy combination in frontline treatment of mPDAC

Clover Biopharmaceuticals enrols first participants in Phase 2 trial of respiratory combination vaccine candidates